Speakers from Pulsar Helium and Eurasia Mining are presenting and taking Q&A at focusIR's Investor Webinar next week. Register here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here

Pin to quick picksIQ-AI Share News (IQAI)

Share Price Information for IQ-AI (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.825
Bid: 0.80
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.05 (6.25%)
Open: 0.825
High: 0.825
Low: 0.825
Prev. Close: 0.825
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Timelines are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Chesterfield Lands Polymetal Investment

Thu, 26th Nov 2020 18:00

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Chesterfield Resources PLC - copper explorer focused on Cyprus - Lands GBP2.1 million investment from Polymetal International PLC. Gold miner takes 23% stake in Chesterfield. "Polymetal will become the largest shareholder in Chesterfield and a strategic partner," Chesterfield says.

----------

Blencowe Resources PLC - developing Orom-Cross jumbo flake graphite project in Uganda - Expects maiden JORC-compliant resource at Orom-Cross graphite project in early first-quarter. " Leading graphite specialists SGS Lakefield undertaking phase two metallurgical work on track to deliver results in Q1 2021," Blencowe says.

----------

W Resources PLC - London-based tungsten, tin and gold mining company with assets in Spain and Portugal - Says plant improvements at La Parrilla tungsten and tin project in Spain have "consolidated" recoveries so far during fourth quarter. "Following the improvements that led to such a strong September, I am greatly encouraged that this momentum has continued into Q4," La Parrilla Managing Director Pablo Neira says.

----------

Panthera Resources PLC - gold exploration and development company with assets in West Africa and India - Says fieldwork to begin at Kalaka gold project, Mali next week. "The Kalaka project is a very large gold system with historical drilling consistently reporting significant gold intercepts," Managing Director Mark Bolton says.

----------

Serinus Energy PLC - upstream oil and gas exploration and production company that owns and operates projects in Tunisia and Romania - Plans to raise USD20 million through a placing via an accelerated bookbuild. "The proceeds of the placing will be used as part of a proposal to retire the EBRD convertible debt, and for the installation of the first pumps in a well work over programme for the Sabria field in Tunisia," Serinus says.

----------

Savannah Resources PLC - resource development company with operations in Portugal, Mozambique and Oman - Says next stage of environmental impact assessment work at Mina do Barroso lithium project completed. Company submits "additional and revised information" to Portuguese regulatory body.

----------

Greencoat Renewables PLC - renewable energy company - Proposes placing to raise EUR100 million. "In line with strategy, the proceeds of the placing will be used to pay down the company's existing revolving credit facility and provide financial flexibility to take advantage of a pipeline in excess of EUR500 million in value accretive acquisition opportunities in Ireland and in other target European countries," Greencoat says.

----------

Mirriad Advertising PLC - advertising agency - Plots placing to raise GBP23 million through issue of up to 57.6 million shares at 40 pence. "The net proceeds from the placing will be used for general working capital purposes in pursuit of the company's existing strategy," Mirriad says.

----------

APQ Global Ltd - Guernsey-based emerging markets investor - Disposes of stake in City of London Investment Group PLC. Held 1.7 million shares in company and nets GBP7.2 million from sale.

----------

GRC International Group PLC - holding company for a group of companies providing a range of products and services to address the IT governance and risk management - Launches GDPR services to help companies manage Brexit. "GRC International Group's EU and UK Representative Services are fast, efficient and affordable services that allow organisations to easily and quickly meet their compliance obligations under Article 27 of the GDPR," GRC says.

----------

Proton Motor Power Systems PLC - fuel cells company - Given clearance to announce details from European order. Says order consists of integrating fuel cell into rail milling machine as part of project devised by Austrian firm Linsinger Maschinenbau Gesellschaft mbH. "Proton Motor will be delivering a 214 kilowatt hydrogen fuel cell system specifically adapted to Linsinger's requirements," Proton says.

----------

Actual Experience PLC - analytics as a service company - Receives purchase order for "major deployment" of recently launched Human Experience Management platform. "This opportunity represents a significant milestone for the company," Actual says. Company adds order came from a channel partner whose customer is a "leading global energy supplier".

----------

EKF Diagnostics Holdings PLC - Cardiff-based diagnostics and central laboratory assay manufacturer - Notes partner Kantaro Biosciences LLC gets US Food & Drug Administration emergency use approval for SeroKlir SARS-CoV-2 IgG antibody test kit. "EKF has exclusive rights to market and distribute COVID-SeroKlir, a quantitative SARS-CoV-2 IgG antibody test kit, in the UK and Germany and non-exclusive rights in Europe," EKF says. Adds it has sold 1.7 million Renalytix AI PLC shares for GBP7.7 million.

----------

IQ-AI Ltd - medical software company with headquarters in Jersey - Unit Imaging Biometrics makes latest IB Clinic software platform available. "The new release incorporates multiple new enhancement requests received from clients, as well as workflow efficiencies engineered by IB's developers. Ultimately, this release underscores IB's commitment to quality and helping clinicians improve care for their patients," IQ-AI says.

----------

Randall & Quilter Investment Holdings Ltd - insurance company - Says Oklahoma Insurance Commissioner approves insurance business transfer of a portfolio belonging to Sentry Insurance to National Legacy Insurance Co, a Randall unit.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 May 2025 13:28

IN BRIEF: IQ-AI applies for breakthrough therapy designation for GaM

IQ-AI Ltd - London-based medical services company - Says subsidiary Imaging Biometrics LLC has applied for breakthrough therapy designation from the US Food & Drug Administration for its oral gallium maltolate therapy. Its phase 1 trial is evaluating the therapy as a potential treatment for adult patients with recurrent or refractory glioblastoma IDH-wildtype, with preliminary findings suggesting an overall survival of 34.1 months from initial diagnosis. This significantly exceeds the median survival of 14 to 15 months reported for patients undergoing standard treatment, though IQ-AI notes that caution is appropriate when considering the results due to the size of the trial population. The FDA is required to respond to IQ-AI's application within 60 days.

Read more
3 Feb 2025 19:22

IN BRIEF: IQ-AI amends distribution deal with Blackford Analysis

IQ-AI Ltd - London-based medical services company - Amends existing distribution agreement with artificial intelligence platform provider Blackford Analysis Ltd. The amendment adds IB Nimble, IB ASL, IB FTB, and IB FTB Express to the agreement, allowing Blackford to also sell these products to their global client base. Acquired by Bayer in early 2023, Blackford operates in the healthcare AI platform and solutions sphere.

Read more
22 Jan 2025 17:10

IN BRIEF: IQ-AI to take GaM to phase II study, flags AI capabilities

IQ-AI Ltd - London-based medical services company - Provides operations update focusing on artificial intelligence. Explains radiology leads the way in Food & Drug Administration approvals for AI-enabled products as the FDA has increased efforts to keep pace with the advancements in AI technology. The company believes its subsidiary, Imaging Biometrics LLC, is in a unique position to lead this transformation for neuro-oncology in 2025 and beyond. Points to the imminent release of the new version of IB Clinic; its FDA-cleared suite of quantitative imaging solutions will include the incorporation of an AI model, which will greatly improve diagnostic accuracy and speed. In addition, notes the first half of 2025 should mark the next release of IB Nimble with the functionality to view IB's AI-generated images and other images within the mobile app. Also, in 2025 we anticipate releasing a new product leveraging arterial spin labelling.

Read more
14 Oct 2024 10:05

IN BRIEF: Braveheart buys 30% stake in IQ-AI from Braveheart CEO Brown

IQ-AI Ltd - parent of Wisconsin-based Imaging Biometrics LLC, which provides quantitative imaging platforms and therapeutics for the diagnosis and treatment of patients - AIM-listed technology investor Braveheart Investment Group PLC buys a nearly 30% stake in IQ-AI from Braveheart Chief Executive Officer Trevor Brown. Braveheart buys 45.8 million IQ-AI shares from Brown at 1.1 pence per share, worth GBP503,372, and another 19.7 million shares owned by Brown's children at the same price, worth GBP216,203. The two purchases give Braveheart a 29.5% stake in IQ-AI. Braveheart on Friday says the related-party transaction is approved by its independent shareholders because the IQ-AI business fits Braveheart's investment strategy and the purchase is at "an attractive entry price".

Read more
16 Aug 2024 20:40

TRADING UPDATES: NetScientific loss narrows; Vinanz ups Bitcoin fleet

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and Wednesday and not separately reported by Alliance News:

Read more
25 Jun 2024 11:56

IN BRIEF: IQ-AI subsidiary opens expanded access programme

IQ-AI Ltd - London-based medical services company - US-based subsidiary Imaging Biometrics LLC says that US Food & Drug Administration has approved an expanded access programme for oral gallium maltolate. This EAP will run in parallel with the current phase 1 clinical trial being conducted at the Medical College of Wisconsin. Explains that "As the phase 1 trial concludes this fall and while the data is being compiled, eligible patients in the US will have the option of participating in the EAP."

Read more
14 Jun 2024 14:32

IQ-AI team begins defining phase 2 protocol for oral gallium maltolate

(Alliance News) - IQ-AI Ltd on Friday said the clinical team has started a phase 2 protocol for its oncology-focused drug oral gallium maltolate, which could be a therapeutic agent for cancer.

Read more
23 May 2024 21:08

TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
20 May 2024 11:16

IQ-AI subsidiary gets second FDA rare paediatric disease designation

(Alliance News) - IQ-AI Ltd on Monday said its subsidiary, Imaging Biometrics LLC, received a second rare paediatric disease designation by the US Food & Drug Administration for its IB-003 lead drug candidate oral gallium maltolate.

Read more
17 May 2024 17:39

TRADING UPDATES: Ingenta trades in line; Triple Point Social NAV up

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
10 May 2024 15:14

IQ-AI subsidiary gets rare paediatric disease designation FDA

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary, Imaging Biometrics LLC, has been granted rare paediatric disease designation by the US Food & Drug Administration for its lead drug candidate, IB-003, or gallium maltolate for the treatment of ATRT.

Read more
2 May 2024 15:45

EARNINGS AND TRADING: Trident Royalties swings to profit

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Feb 2024 14:02

IN BRIEF: IQ-AI shares sink on discounted placing fundraise

IQ-AI Ltd - Medical services firm and parent company of Wisconsin-based healthcare imaging software firm Imaging Biometrics LLC - Announces placing to raise GBP300,000 gross proceeds via the issue of 20.0 million new shares at a price of 1.5p each. The issue price represents a discount of 32% to the company's Wednesday closing price of 2.2p. The placing includes a broker option for existing shareholders for up to 6.7 million new shares, which would raise an additional GBP100,000. Admission of the new placing and broker option shares is expected to occur on or around March 1.

Read more
9 Feb 2024 13:38

IQ-AI subsidiary asked by FDA to resubmit and modify application

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary Imaging Biometric LLC will modify and resubmit its application to the US Food & Drug Administration.

Read more
2 Feb 2024 08:56

IN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiary

IQ-AI Ltd - St Helier, Jersey-based medical services firm - Says that Imaging Biometrics LLC, a wholly-owned subsidiary of IQ-AI, has been given a USD100,000 grant by the Musella Foundation For Brain Tumor Research & Information Inc. Explains that the grant will help to support the launch of an intermediate group expanded access programme, which is focused on giving brain tumour patients access to oral gallium maltolate, outside of an ongoing Phase One clinical trial at the Medical College of Wisconsin. The grant will be used to facilitate the expanded access programme, including writing and submitting the study protocol, patient screening and on-boarding.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.